Cargando…

Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC

SIMPLE SUMMARY: Highly aggressive cutaneous squamous-cell carcinomas (cSCCs) are the primary cause of death in patients with the rare skin disease recessive dystrophic epidermolysis bullosa (RDEB). Currently the detection of RDEB-SCCs requires invasive skin biopsies with a high burden for patients a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zauner, Roland, Wimmer, Monika, Atzmueller, Sabine, Proell, Johannes, Niklas, Norbert, Ablinger, Michael, Reisenberger, Manuela, Lettner, Thomas, Illmer, Julia, Dorfer, Sonja, Koller, Ulrich, Guttmann-Gruber, Christina, Hofbauer, Josefina Piñón, Bauer, Johann W., Wally, Verena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340387/ https://www.ncbi.nlm.nih.gov/pubmed/37444397 http://dx.doi.org/10.3390/cancers15133286

Ejemplares similares

Transcriptome-Guided Drug Repurposing for Aggressive SCCs
por: Zauner, Roland, et al.
Publicado: (2022)

COL7A1 Editing via RNA Trans-Splicing in RDEB-Derived Skin Equivalents
por: Liemberger, Bernadette, et al.
Publicado: (2023)

A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas
por: Wimmer, Monika, et al.
Publicado: (2020)

5′RNA Trans-Splicing Repair of COL7A1 Mutant Transcripts in Epidermolysis Bullosa
por: Mayr, Elisabeth, et al.
Publicado: (2022)

Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa
por: Ablinger, Michael, et al.
Publicado: (2021)

Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases
por: Kocher, Thomas, et al.
Publicado: (2017)

Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex
por: Ablinger, Michael, et al.
Publicado: (2018)

Topical Diacerein Decreases Skin and Splenic CD11c(+) Dendritic Cells in Psoriasis
por: Brunner, Susanne M., et al.
Publicado: (2023)

A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa
por: Zwicklhuber, Janine, et al.
Publicado: (2023)

Current Surgical Therapy of Locally Advanced cSCC: From Patient Selection to Microsurgical Tissue Transplant. Review
por: Brambullo, Tito, et al.
Publicado: (2021)

TRAF6 regulates EGF-induced cell transformation and cSCC malignant phenotype through CD147/EGFR
por: Zhang, Xu, et al.
Publicado: (2018)

Loss of retinoic acid receptor-related receptor alpha (Rorα) promotes the progression of UV-induced cSCC
por: Zhang, Guolong, et al.
Publicado: (2021)

Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review
por: Farberg, Aaron S., et al.
Publicado: (2022)

Complement Factor H in cSCC: Evidence of a Link Between Sun Exposure and Immunosuppression in Skin Cancer Progression
por: Johnson, Ellise M., et al.
Publicado: (2022)

A late presentation of inguinoscrotal cutaneous squamous cell carcinoma (cSCC) masquerading as hidradenitis suppurativa—a case report
por: Lahham, Elias Edward, et al.
Publicado: (2023)

COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa
por: Petković, Igor, et al.
Publicado: (2022)

RNA Trans-Splicing Modulation via Antisense Molecule Interference
por: Liemberger, Bernadette, et al.
Publicado: (2018)

Can we be SMaRT-er in our approach to cancer therapy?
por: Gruber, Christina, et al.
Publicado: (2015)

lncRNA EZR-AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway
por: Lu, Di, et al.
Publicado: (2021)

Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort Study
por: Bailly-Caillé, Barbara, et al.
Publicado: (2023)

Signatures of Dermal Fibroblasts from RDEB Pediatric Patients
por: Beilin, Arkadii K., et al.
Publicado: (2021)

IMP3 Expression as a Potential Tumour Marker in High-Risk Localisations of Cutaneous Squamous Cell Carcinoma: IMP3 in Metastatic cSCC
por: Klein, Maurice, et al.
Publicado: (2023)

Radiotherapy in the Adjuvant and Advanced Setting of CSCC
por: Muto, Paolo, et al.
Publicado: (2021)

Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa
por: Bischof, Johannes, et al.
Publicado: (2022)

Linked in: the extracellular matrix network in tumour dissemination
por: Leb‐Reichl, V., et al.
Publicado: (2020)

Epigenetic and metabolic regulation of epidermal homeostasis
por: Wagner, Roland N., et al.
Publicado: (2021)

Recessive dystrophic epidermolysis bullosa (RDEB) complicated by secondary hepatic amyloidosis
por: Chaptini, Cassandra, et al.
Publicado: (2015)

Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer
por: Woess, Katharina, et al.
Publicado: (2022)

Small molecule drug development for rare genodermatoses – evaluation of the current status in epidermolysis bullosa
por: Wally, Verena, et al.
Publicado: (2020)

Incorporation of the 40-Gene Expression Profile (40-GEP) Test to Improve Treatment Decisions in High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients: Case Series and Algorithm
por: Singh, Gaurav, et al.
Publicado: (2023)

An ex vivo RNA trans‐splicing strategy to correct human generalized severe epidermolysis bullosa simplex
por: Peking, P., et al.
Publicado: (2018)

Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis Bullosa
por: Welponer, Tobias, et al.
Publicado: (2021)

Cost of illness del carcinoma cutaneo a cellule squamose (CSCC)
por: Marcellusi, Andrea, et al.
Publicado: (2020)

From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
por: Eichstadt, Shaundra, et al.
Publicado: (2019)

372 HMGB1 Localization as a Driver of Carcinogenesis in RDEB-Associated Squamous Cell Carcinoma
por: Bui, Kacey Guenther, et al.
Publicado: (2023)

MMP-9 and CXCL8/IL-8 Are Potential Therapeutic Targets in Epidermolysis Bullosa Simplex
por: Lettner, Thomas, et al.
Publicado: (2013)

From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB) [Corrigendum]
Publicado: (2021)

Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB
por: Georgiadis, Christos, et al.
Publicado: (2016)

hTERT-Driven Immortalization of RDEB Fibroblast and Keratinocyte Cell Lines Followed by Cre-Mediated Transgene Elimination
por: Evtushenko, Nadezhda A., et al.
Publicado: (2021)

Recessive dystrophic epidermolysis bullosa (RDEB): Oral manifestation and management rules in oral surgery: A case report
por: El Yacoubi, Oumayma, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kjfh5q7cfqnep617eg9e9tnu9v